IL6 and COVID-19: Following intranasal administration, by five days the mice had developed evidence of lung infection and immune cell infiltration (18), with production of inflammatory mediators, including CCL2, IL-6, IL-12p40 and IL-1RA; these cytokines were also elevated acutely in the serum of COVID-19 patients with low Glasgow coma scale scores (7).